Antibiotic Dosing in Multiple Organ Dysfunction Syndrome

被引:79
|
作者
Ulldemolins, Marta [1 ,2 ,3 ]
Roberts, Jason A. [2 ,4 ,5 ]
Lipman, Jeffrey [2 ,4 ]
Rello, Jordi [1 ,3 ]
机构
[1] Univ Autonoma Barcelona, Crit Care Dept, Vall Hebron Univ Hosp, VHIR, Barcelona 08035, Spain
[2] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[3] CIBERES, Barcelona, Spain
[4] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; SEVERE SEPSIS; CLINICAL PHARMACOKINETICS; ANTIMICROBIAL THERAPY; GLOMERULAR-FILTRATION; ANTIBACTERIAL AGENTS; CREATININE CLEARANCE; HYPOALBUMINEMIA; PREDICTION;
D O I
10.1378/chest.10-2371
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Although early and appropriate antibiotic therapy remains the cornerstone of success for the treatment of septic shock, few data exist to guide antibiotic dose optimization in critically ill patients, particularly those with multiple organ dysfunction syndrome (MODS). It is well known that MODS significantly alters the patient's physiology, but the effects of these variations on pharmacokinetics have not been reviewed concisely. Therefore, the aims of this article are to summarize the disease-driven variations in pharmacokinetics and pharmacodynamics and to provide antibiotic dosing recommendations for critically ill patients with MODS. The main findings of this review are that the two parameters that vary with greatest significance in critically ill patients with MODS are drug volume of distribution and clearance. Disease- and clinician-driven changes lead to an increased volume of distribution and lower-than-expected plasma drug concentrations during the first day of therapy at least. Decreased antibiotic clearance is common and can lead to drug toxicity. In summary, "front-loaded" doses of antibiotic during the first 24 11 of therapy should account for the likely increases in the antibiotic volume of distribution. Thereafter, maintenance dosing must be guided by drug clearance and adjusted to the degree of organ dysfunction. CHEST 2011; 139(5):1210-1220
引用
收藏
页码:1210 / 1220
页数:11
相关论文
共 50 条
  • [31] Multiple Organ Dysfunction Syndrome in Critical Surgical Illness
    Barie, Philip S.
    Hydo, Lynn J.
    Pieracci, Fredric M.
    Shou, Jian
    Eachempati, Soumitra R.
    SURGICAL INFECTIONS, 2009, 10 (05) : 369 - 377
  • [32] Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome
    Marshall, JC
    CRITICAL CARE MEDICINE, 2001, 29 (07) : S99 - S106
  • [34] Epidemiology of sepals and multiple organ dysfunction syndrome in children
    Proulx, F
    Fayon, M
    Farrell, CA
    Lacroix, J
    Gauthier, M
    CHEST, 1996, 109 (04) : 1033 - 1037
  • [35] Multiple organ dysfunction syndrome: infection or hypersensitivity reaction?
    Dreesman, Alexandra
    Hoorens, Anne
    Hachimi-Idrissi, Said
    EUROPEAN JOURNAL OF EMERGENCY MEDICINE, 2010, 17 (04) : 228 - 233
  • [36] Platelet function in septic multiple organ dysfunction syndrome
    M. Gawaz
    T. Dickfeld
    C. Bogner
    S. Fateh-Moghadam
    F. J. Neumann
    Intensive Care Medicine, 1997, 23 : 379 - 385
  • [37] Fecal microbiota transplantation for multiple organ dysfunction syndrome
    Nathan J. Klingensmith
    Craig M. Coopersmith
    Critical Care, 20
  • [38] Multiple organ dysfunction syndrome (MODS) in the obstetric population
    Curran, CA
    JOURNAL OF PERINATAL & NEONATAL NURSING, 2002, 15 (04) : 37 - 55
  • [39] KIDNEY INJURY INCIDENCE IN MULTIPLE ORGAN DYSFUNCTION SYNDROME
    Gorga, Stephen
    Carlton, Erin
    Kohne, Joseph
    Barbaro, Ryan
    CRITICAL CARE MEDICINE, 2020, 48
  • [40] Platelet function in septic multiple organ dysfunction syndrome
    Gawaz, M
    Dickfeld, T
    Bogner, C
    FatehMoghadam, S
    Neumann, FJ
    INTENSIVE CARE MEDICINE, 1997, 23 (04) : 379 - 385